PSYC 210 Lecture Notes - Lecture 23: Binge Eating Disorder, Frontotemporal Dementia, Disordered Eating
30 Apr 2018
School
Department
Course
Professor
Learning Catalytics
Mary, a 70-year-old woman, was hospitalized for hip surgery. Although there
were no immediate complications from the surgery, her son became concerned
when he visited her that night because she was not making any sense. She
thanked him for checking her into the Ritz Carlton and laughed giddily when he
told her that she was in the hospital. Half an hour later, she began sobbing.
Although she seemed fine the next morning, symptoms of acute confusion
reemerged by lunchtime. Which diagnosis is most likely for Mary?
Delirium
A.
!"#$%#%&'(#")*+,&'&$%-)
./
.-(#*)"+0-1#",&"
2/
3*45&-'&"61+,-1&)1&
0/
7'(#"%)$%+-$8#9+%5&+%-'-$:+)$,+,&:"&&+#8+;5)$:&
!"#$%#%&'(#")*+,#&1$6%+15#<+')11-=&+,")')%-;+;5)$:&1+#=&"+$-:5%
>
?#+#%5&"+;)@1&A+;#@*,+1&&'+*-B&+")(-,+#$1&%
>
CD=-#@1+;)$,-,)%&+E%5&+)$&1%5&1-)+;)$+5)=&+"&1-,@)*+)8%&"+&88&;%1
>
Which neurotransmitter is most involved in the treatment of Alzheimer’s disease?
0#()'-$&
3/
F&"#%#$-$
./
G*@%)')%&
2/
Acetylcholine
H"&)%'&$%+-1+)$+-$5-D-%#"+#$+%5-1+1I1%&'
○
D.
The most successful treatments for eating disorders are (select all that apply):
CBT
A.
Family5Therapy
B.
3$%-,&("&11)$%1
2)$+D&+@1&,+%#+%"&)%+;#'#"D-,+)$J-&%I+#"+,&("&11-#$
)/
0#&1+$#%+-'("#=&+%5&+K0+-%1&*8
D/
2/
.&$4#,-)4-(-$&1
0/
3$%-(1I;5#%-;1
K/
The main distinguishing factor between anorexia and bulimia is:
.-$:-$:LM@":-$:
H5&"&+-1+)+1@D%I(&+-$+)$#"&J-)
○
3/
Body5weight
3$#"&J-)+E5)=&+)$+)D$#"')*+D#,I+<&-:5%
○
.@*-'-)+E')-$%)-$+)+$#"')*+D#,I+<&-:5%
○
B.
2#:$-%-=&+,-1%#"%-#$1+)"#@$,+D#,I+-'):&2/
(##"+-'(@*1&+;#$%"#*0/
Lifetime prevalence for eating disorders is:
1-3%A.
NOPQ./
RSQ2/
RNQ0/
T&*)%-=&*I+")"&+-$+%&"'1+#8+'&&%-$:+8@**+;"-%&"-)
0-1#",&"&,+&)%-$:+-1+$#%+=&"I+")"&
K1(&;-)**I+<-%5+#%5&"+;#'#"D-,+,-1#",&"1
○
>
U-8&%-'&+("&=)*&$;&+#8+&)%-$:+,-1#",&"1+-1+"&*)%-=&*I+*#<+VROWQX>
Anorexia)Nervosa
25)");%&"-4&,+DI9
Y$5&)*%5I+D#,I+<&-:5%>
M"&#;;@()%-#$+<-%5+D#,I+-'):&>
F@D%I(&1+#8+"&1%"-;%-=&+#"+D-$:&L(@":&>
0FZON+;"-%&"-)+8#"+ANOREXIA5NERVOSA
T&1%"-;%-#$
T&1%"-;%-#$+D&5)=-#"1+V.Z7+[+R\/NX3/
1.
]&-:5%O"&*)%&,+)$J-&%I
7$%&$1&+8&)"+#8+<&-:5%+:)-$3/
?#+1@;5+%5-$:+)1+^%##+%5-$^./
2.
0-1%#"%&,+D#,I+-'):&
M"&#;;@()%-#$+<-%5+)((&)")$;&+)$,+D#,I+()"%13/
3.
]5)%+-1+)+5&)*%5I+<&-:5%_
`&)*%5I9+R\Oab>
.Z7+1&=&"-%I9
Z-*,9+cRP
○
Z#,&")%&9+RdORP
○
F&=&"&9+RNORP
○
KJ%"&'&9+[RN
○
>
M5I1-;)*+')"B&"1+#8+*#<+<&-:5%
K');-)%&,+)((&)")$;&
○
!)%-:@&
○
0-44-$&11+#"+8)-$%$&11
○
."-%%*&L;");B&,+$)-*1+V$#%+&$#@:5+;)*;-@'X
○
H5-$$-$:+5)-"
○
Z&$1%"@)*+;I;*&+-""&:@*)"-%-&1+
○
>
U)D#")%#"I+')"B&"1+#8+*#<+<&-:5%9
U&@B#(&$-)+V*#<+;&**+ ;#@$%X
○
K*&=)%-#$1+-$+5&()%-;+V*-=&"X+&$4I'&1
○
F-$@1+D"),I;)",-)
`&)"%+-""&:@*)"-%I+V*#<&"+%5)$+dS+D('X
§
○
U#<+D#$&+')11
○
U#<+"&1%-$:+'&%)D#*-;+);%-=-%I
.#,I+%"I-$:+%#+1)=&+&$&":I
§
○
U#<+1&J+5#"'#$&1
K1%"#:&$+8#"+<#'&$
§
H&1%#1%&"#$&+8#"+'&$
§
○
>
M5I1-;)*+)$,+*)D+')"B&"1+`KUM+;#$8-"'+)+,-):$#1-1A+D@%+,#$6%+,&8-$&+-%
F#'&#$&+-$+),#*&1;&$;&+<)1+=&"I+%5-$+D@%+,#$6%+<#""I+)D#@%+8##,A+)$,+
8"#'+D#,I61+(&"1(&;%-=&+-1+#B)I
○
?CH+)+,&8-$-%-=&+,-):$#1%-;+%&1%
○
>
7$O;*)11+=-,
3+*#%+#8+,&$-)*+)$,+,-1%#"%-#$
2)$+;#'&+;*#1&+%#+,I-$:+8"#'+')*$@%"-%-#$+D&8#"&+)$I+);%-#$+-1+%)B&$
○
>
7$%&$1&+"&1%"-;%-=&+D&5)=-#"1+
F%)"%&,+*#1-$:+<&-:5%A+%5&$+1%)"%&,+5)$:-$:+#@%+<-%5+8"-&$,1+<&**
○
!-:@"&+#@%+)+<)I+%#+"&1%"-;%+)$,+in#the#initial#stages,#get#a#lot#of#positive#
reinforcement
T&)88-"'1+-,&)+%5)%+I#@+5),+D&&$+#=&"<&-:5%+)$,+;#$%"#**-$:+<&-:5%+
-1+)+(#<&"8@*+)$,+@1&8@*+%5-$:+%#+,#
§
○
>
Being5underweight5has5a5lot5more5severe5consequences5and5may5require5emergency5
treatmentA+1#+)$#"&J-)+)$,+D@*-'-)+)"&+1&()")%&+,-):$#1&1
Bulimia
Bulimia9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*A+;#'(&$1)%-$:A+#=&"O&=)*@)%-#$+#8+<&-:5%+
)$,+15)(&
Binges9+'@;5+'#"&+8##,+%5)$+)+$#"')*+(&"1#$+<#@*,+&)%+-$+)+15#"%+)'#@$%+#8+
%-'&
3*1#+1#'&+(&#(*&+;)$+e@1%+&)%+)+*#%+)%+#$&+%-'&A+D@%+$#%+D&+D@*-'-;
○
0-1;"-'-$)%-#$+D&%<&&$+,-1#",&"&,+D-$:&+)$,+)+:"#<%51+1(@"%+;)$+D&+
%"-;BI+D)1&,+#$+%5-1+;"-%&"-)
○
C%5&"+%5-$:1+%&$,+%#+:#+)*#$:+<-%5+,-1#",&"&,+D-$:&1+%5)%+')B&+%5&'+
'#"&+#D=-#@1
F&*8O;#$1;-#@1$&11L15)'&
§
M&"1#$+B$#<1+%5&I6"&+&)%-$:+'#"&+%5)$+%5&I+15#@*,+#"+$&&,+%#
§
HI(-;)**I+1%)"%+-$+1&;"&%+8#"+1&*8O;#'8#"%
§
○
78+%5&I6"&+e@1%+:)-$-$:+<&-:5%+)$,+$#%+,#-$:+)$I%5-$:A+-%61+binge-eating5
disorder
○
>
Compensatory5behaviors5are5to5counteract5the5effects5of5the5binge
0#&1$6%+')%%&"+5#<+&88&;%-=&+-%+-1
○
2)$+1#'&%-'&1+,&(&$,+#$+,"@:1+*-B&+'&%5+)$,+3,,&")**+%5)%+,&;"&)1&+
)((&%-%&+
○
>
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+<&-:5%
U&11+#8+)+,-1%#"%-#$A+'#"&+)+;5"#$-;+()%%&"$+#8+,-11)%-18);%-#$
○
>
F&=&"-%I+D)1&,+#$+$@'D&"+#8+;#'(&$1)%#"I+D&5)=-#"1 (&"+<&&B9
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
0FZON+;"-%&"-)+8#"+.YU7Z73+?KTgCF3
.-$:&1
T&;@""&$%+D-$:&13/
R+(&"+<&&B+8#"+W+'#$%51./
1.
2#'(&$1)%#"I+D&5)=-#"
g#'-%-$:3/
U)J)%-=&1./
KJ%"&'&+&J&";-1&2/
2.
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+-'):&
U#<+1&*8+&1%&&'+,@&+%#+D#,I+-'):&3/
3.
Binge)Eating)Disorder
Binge5eating5disorder9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*h+$#+;#'(&$1)%-$:
CD&1-%I+)$,+#=&"&)%-$:+)"&+'@;5+'#"&+("&=)*&$%+%5)$+D-$:&+&)%-$:+,-1#",&"+>
.-$:&+&)%-$:+1&=&"-%I+D)1&,+#$+$@'D&"+#8+D-$:&1
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
`)1+;#$%#@"1+#8+1@D1%)$;&+)D@1&A+'#"&+1#+%5)$+#%5&"+,-1#",&"1
.-$:&1+)"&+)**+;#$1@'-$:
○
U##B1+)+*#%+'#"&+$&@"#O;5&'-;)**I+*-B&+1@D1%)$;&+)D@1&
0#()'-$&+"&1(#$1&1+%#+8##,+"&*)%&,+;@&1
§
○
Z)B&1+-%+,-88&"&$%+8"#'+#%5&"+K01+D&;)@1&+#8+),,-;%-=&+"&1(#$1&+%#+8##,1
○
0-88-;@*%+D&;)@1&+I#@+5)=&+%#+&)%+Ealways5easier5to5abstain5that5use5in5
moderation <5&$+I#@6"&+),,-;%&,+%#+1#'&%5-$:
78+I#@+8-$,+-%+&)1-&"+%#+)D1%)-$+%5)$+@1&+1#'&%5-$:+-$+'#,&")%-#$A+-1+
)+1-:$+%5)%+I#@+')I+5)=&+)$+),,-;%-#$
§
]&6"&+1)%@")%&,+DI+),=&"%-1&'&$%1+%"I-$:+%#+:")D+#@"+)%%&$%-#$+%#+
@$5&)*%5I+8##,
."-:5%+;#*#"&,+();B):-$:A+8)1%+8##,i
§
○
>
F%@,I+<-%5+,-&%
H<#+:"#@(19
C":)$-;+5-:5+8)%+*#<+;)"D
§
C":)$-;+5-:5+;)"D+)$,+*#<+8)%+,-&%
§
○
.#%5+*#1%+)+*#%+#8+<&-:5%+)$,+1)'&+)'#@$%
0-,$6%+')%%&"
§
○
7'(#"%)$;&9+,-,+$#%+&)%+)$I%5-$:+("#;&11&,
○
>
0FZON+;"-%&"-)+8#"+.7?GK+K3H7?G+07FCT0KT
.-$:&1
T&;@""&$%+D-$:&13/
R++(&"+<&&B+8#"+W+'#$%51./
R/
.-$:&1+'@1%+-$;*@,&
K)%-$:+j@-;B*I3/
K)%-$:+)*#$&./
K)%-$:+@$%-*+#=&"+8@**2/
F&*8O*#)%5-$:+)8%&"<)",10/
a/
3D1&$;&+#8+;#'(&$1)%#"I+D&5)=-#"W/
K0+,-):$#1%-;+,-88&"&$%-)*1+k1&&+1*-,&l
F-:$-8-;)$%*I+*#<+.Z7
m&1+E3$#"&J-)
2#'(&$1)%-#$1_+.-$:&1_
?#E"&1%"-;%-=&+1@D%I(&
§
m&1+ED-$:&L(@":&+1@D%I(&
§
○
>
?#+ED-$:&1_>
Prevalence
3:&+#8+#$1&%
3$#"&J-)9+H&&$1L&)"*I+aS1>
?#+):&+;@%+#88+8#"+D-$:&O&)%-$:>
2#'#"D-,-%I
`-:5+;#'#"D-,-%I+<-%5+)$J-&%IA+,&("&11-#$A+1@D1%)$;&+)D@1&
U#<+D#,I+<&-:5%+*&),1+%#+')*$#@"-15'&$%+)$,+'##,+1I'(%#'1
0&("&11-#$+-1+%I(-;)**I+1&;#$,)"I+%#+)$#"&J-)
§
○
>
0&(&$,1+#$+-$,-=-,@)*+;)1&+5#<+,-1%-$;%+#"+-$%&";#$$&;%&,+%5&+;#'#"D-,-%I+-1
71+%5&+,&("&11-#$+,"-=-$:+%5&+;#'(&$1)%#"I+D&5)=-#"_
○
0&("&11&,+D&8#"&+K0_+C"+-1+,&("&11-#$+)+;#$1&j@&$;&+#8+K0+D&5)=-#"+)$,+
&88&;%1_
○
>
2#''#$+5)*8O%"@%51
K)%-$:+,-1#",&"1+)"&+")"&
2*-$-;)*+&)%-$:+,-1#",&"1+)"&+@$;#''#$A+D@%+,-1#",&"&,+&)%-$:+-1+
("&=)*&$%
○
`I(&"+8#;@1+#$+&)%-$:9+NNQ+#8+8&')*&1+)$,+aNQ+#8+')*&1+"&(#"%+,-&%-$:/+
RaQ+8&')*&1+)$,+WQ+')*&1+"&(#"%+D-$:&+&)%-$:
○
>
K)%-$:+,-1#",&"1+("-')"-*I+)88&;%+)88*@&$%+<5-%&+<#'&$
0-88&"&$%-)*+("&1&$%)%-#$1+DI+:&$,&"+)$,+");-)*L&%5$-;+D);B:"#@$,
○
0-88&"&$;&1+-$+<5#+1&&B1+%"&)%'&$%
○
?CH+,-1()"-%I+-$+("&=)*&$;&
○
>
H5&I+)"&+;)@1&,+DI+]&1%&"$+;@*%@"&
Z#1%+("&=)*&$%+-$+]&1%&"$+;@*%@"&
○
F%"#$:+:&$&%-;+;#'(#$&$%+VWNONNQ++;#$;#",)$;&+-$+'#$#4I:#%-;+%<-$1X
○
.&&$+)"#@$,+8#"+%5#@1)$,1+#8+I&)"1A+D&8#"&+]&1%&"$+;@*%@"&
?#%+)+DI("#,@;%+#8+]&1%&"$+;@*%@"&
§
○
>
H5&+.Z7+-1+)+:##,+'&)1@"&'&$%+#8+D#,I+5&)*%5
M&"1#$+R9+d6N+a\n+*D1A+.Z7+Wa/P+V#D&1&X+D@%+-1+)$+?!U+%-:5%O&$,
!@$;%-#$-$:+("#8&11-#$)*+)%5*&%&
§
○
>
Treatment
Z&,-;)%-#$
3$%-,&("&11)$%1+8#"+;#O'#"D-,+,&("&11-#$A+D@%+$#%+%5&+@$,&"*I-$:+;#"&+-11@&1+#8+
&)%-$:+,-1#",&"1
>
0#$6%+),,"&11+;#"&+8&)"1+#8+<&-:5%+:)-$>
2)$6%+"&'#=&+"&1%"-;%-=&+D&5)=-#"1>
2.H
Z#1%+<&**+1%@,-&,>
NSQ+&88&;%-=&>
!)'-*IO.)1&,+H5&")(I9+[NSQ+)%+D&1%
F#'&+@$<)$%&,+1-,&+&88&;%1
U-B&+#$*I+&)%-$:+<-%5+()"&$%)*+&$;#@"):&'&$%
§
U&)"$1+%#+&)%+)(("#("-)%&*I+#$*I+<5&$+D&-$:+;*#1&*I+'#$-%#"&,
U#1&+1B-**1+<5&$+*&)=-$:+5#'&+i
§
○
>
M"#;&11+8#"+)$#"&J-)+)$,+D@*-'-)9
7,&$%-8I+;)@1)*+,-1%#"%-#$1
○
H&1%+#@%+D&*-&81+)D#@%+1&*8+)$,+<&-:5%+V1&*8+'#$-%#"-$:X
○
0&(&$,-$:+#$+1&=&"-%IA+-$-%-)*+1%):&1+')I+"&j@-"&+5#1(-%)*-4)%-#$A+8#";&,+
&)%-$:
○
>
!)'-*I+%5&")(I
K0+;)$+#8%&$+)"-1&+-$+),#*&1;&$;&+)1+1I'(%#'+#8+8)'-*I+,I18@$;%-#$
○
H"&)%-$:+8)'-*I+-11@&1+;)$+"&,@;&+,"-=&+8#"+K0+D&5)=-#"
○
K)"*I+<&-:5%O:)-$+("&,-;%1+"&1(#$1&+
○
>
7,&$%-8I-$:+'##,L&=&$%+"&*)%&,+&)%-$:+D&5)=-#"
2)$+5&*(+)=#-,+%5-1+-89
?&&,+%#+:#+-$+<-%5+)+(*)$+D&;)@1&+1&&-$:+%5&+;@&+<-**+;5)$:&+
"&1#*=&
○
○
M"#D*&'1+8#"+$&&,-$:+%5-1+;)$+-$;*@,&9
.-$:-$:+)1+)+,-1%");%-#$
○
.-$:-$:+)$,+;#'(&$1)%-$:+D#%5+,)'(&$+'##,1
○
T&1%"-;%-$:+-$%)B&+%#+8&&*+-$+;#$%"#*L);;#'(*-15&,
○
T&1%"-;%&,+)1+%#+,&'#$1%")%&+)$:&"A+#"+)1+)$+);%+#8+,&8-)$;&
○
○
>
Eating)Disorders
H@&1,)IA+ 3("-*+RPA+aSR\
RR9ad+3Z
Learning Catalytics
Mary, a 70-year-old woman, was hospitalized for hip surgery. Although there
were no immediate complications from the surgery, her son became concerned
when he visited her that night because she was not making any sense. She
thanked him for checking her into the Ritz Carlton and laughed giddily when he
told her that she was in the hospital. Half an hour later, she began sobbing.
Although she seemed fine the next morning, symptoms of acute confusion
reemerged by lunchtime. Which diagnosis is most likely for Mary?
DeliriumA.
!"#$%#%&'(#")*+,&'&$%-)./
.-(#*)"+0-1#",&"2/
3*45&-'&"61+,-1&)1&0/
7'(#"%)$%+-$8#9+%5&+%-'-$:+)$,+,&:"&&+#8+;5)$:&
!"#$%#%&'(#")*+,#&1$6%+15#<+')11-=&+,")')%-;+;5)$:&1+#=&"+$-:5%>
?#+#%5&"+;)@1&A+;#@*,+1&&'+*-B&+")(-,+#$1&%>
CD=-#@1+;)$,-,)%&+E%5&+)$&1%5&1-)+;)$+5)=&+"&1-,@)*+)8%&"+&88&;%1>
Which neurotransmitter is most involved in the treatment of Alzheimer’s disease?
0#()'-$&3/
F&"#%#$-$./
G*@%)')%&2/
Acetylcholine
H"&)%'&$%+-1+)$+-$5-D-%#"+#$+%5-1+1I1%&'
○
D.
The most successful treatments for eating disorders are (select all that apply):
CBTA.
Family5TherapyB.
3$%-,&("&11)$%1
2)$+D&+@1&,+%#+%"&)%+;#'#"D-,+)$J-&%I+#"+,&("&11-#$)/
0#&1+$#%+-'("#=&+%5&+K0+-%1&*8D/
2/
.&$4#,-)4-(-$&10/
3$%-(1I;5#%-;1K/
The main distinguishing factor between anorexia and bulimia is:
.-$:-$:LM@":-$:
H5&"&+-1+)+1@D%I(&+-$+)$#"&J-)
○
3/
Body5weight
3$#"&J-)+E5)=&+)$+)D$#"')*+D#,I+<&-:5%
○
.@*-'-)+E')-$%)-$+)+$#"')*+D#,I+<&-:5%
○
B.
2#:$-%-=&+,-1%#"%-#$1+)"#@$,+D#,I+-'):&
2/
(##"+-'(@*1&+;#$%"#*
0/
Lifetime prevalence for eating disorders is:
1-3%
A.
NOPQ
./
RSQ
2/
RNQ
0/
T&*)%-=&*I+")"&+-$+%&"'1+#8+'&&%-$:+8@**+;"-%&"-)
0-1#",&"&,+&)%-$:+-1+$#%+=&"I+")"&
K1(&;-)**I+<-%5+#%5&"+;#'#"D-,+,-1#",&"1
○
>
U-8&%-'&+("&=)*&$;&+#8+&)%-$:+,-1#",&"1+-1+"&*)%-=&*I+*#<+VROWQX
>
Anorexia)Nervosa
25)");%&"-4&,+DI9
Y$5&)*%5I+D#,I+<&-:5%
>
M"&#;;@()%-#$+<-%5+D#,I+-'):&
>
F@D%I(&1+#8+"&1%"-;%-=&+#"+D-$:&L(@":&
>
0FZON+;"-%&"-)+8#"+ANOREXIA5NERVOSA
T&1%"-;%-#$
T&1%"-;%-#$+D&5)=-#"1+V.Z7+[+R\/NX
3/
1.
]&-:5%O"&*)%&,+)$J-&%I
7$%&$1&+8&)"+#8+<&-:5%+:)-$
3/
?#+1@;5+%5-$:+)1+^%##+%5-$^
./
2.
0-1%#"%&,+D#,I+-'):&
M"&#;;@()%-#$+<-%5+)((&)")$;&+)$,+D#,I+()"%1
3/
3.
]5)%+-1+)+5&)*%5I+<&-:5%_
`&)*%5I9+R\Oab
>
.Z7+1&=&"-%I9
Z-*,9+cRP
○
Z#,&")%&9+RdORP
○
F&=&"&9+RNORP
○
KJ%"&'&9+[RN
○
>
M5I1-;)*+')"B&"1+#8+*#<+<&-:5%
K');-)%&,+)((&)")$;&
○
!)%-:@&
○
0-44-$&11+#"+8)-$%$&11
○
."-%%*&L;");B&,+$)-*1+V$#%+&$#@:5+;)*;-@'X
○
H5-$$-$:+5)-"
○
Z&$1%"@)*+;I;*&+-""&:@*)"-%-&1+
○
>
U)D#")%#"I+')"B&"1+#8+*#<+<&-:5%9
U&@B#(&$-)+V*#<+;&**+ ;#@$%X
○
K*&=)%-#$1+-$+5&()%-;+V*-=&"X+&$4I'&1
○
F-$@1+D"),I;)",-)
`&)"%+-""&:@*)"-%I+V*#<&"+%5)$+dS+D('X
§
○
U#<+D#$&+')11
○
U#<+"&1%-$:+'&%)D#*-;+);%-=-%I
.#,I+%"I-$:+%#+1)=&+&$&":I
§
○
U#<+1&J+5#"'#$&1
K1%"#:&$+8#"+<#'&$
§
H&1%#1%&"#$&+8#"+'&$
§
○
>
M5I1-;)*+)$,+*)D+')"B&"1+`KUM+;#$8-"'+)+,-):$#1-1A+D@%+,#$6%+,&8-$&+-%
F#'&#$&+-$+),#*&1;&$;&+<)1+=&"I+%5-$+D@%+,#$6%+<#""I+)D#@%+8##,A+)$,+
8"#'+D#,I61+(&"1(&;%-=&+-1+#B)I
○
?CH+)+,&8-$-%-=&+,-):$#1%-;+%&1%
○
>
7$O;*)11+=-,
3+*#%+#8+,&$-)*+)$,+,-1%#"%-#$
2)$+;#'&+;*#1&+%#+,I-$:+8"#'+')*$@%"-%-#$+D&8#"&+)$I+);%-#$+-1+%)B&$
○
>
7$%&$1&+"&1%"-;%-=&+D&5)=-#"1+
F%)"%&,+*#1-$:+<&-:5%A+%5&$+1%)"%&,+5)$:-$:+#@%+<-%5+8"-&$,1+<&**
○
!-:@"&+#@%+)+<)I+%#+"&1%"-;%+)$,+in#the#initial#stages,#get#a#lot#of#positive#
reinforcement
T&)88-"'1+-,&)+%5)%+I#@+5),+D&&$+#=&"<&-:5%+)$,+;#$%"#**-$:+<&-:5%+
-1+)+(#<&"8@*+)$,+@1&8@*+%5-$:+%#+,#
§
○
>
Being5underweight5has5a5lot5more5severe5consequences5and5may5require5emergency5
treatmentA+1#+)$#"&J-)+)$,+D@*-'-)+)"&+1&()")%&+,-):$#1&1
Bulimia
Bulimia9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*A+;#'(&$1)%-$:A+#=&"O&=)*@)%-#$+#8+<&-:5%+
)$,+15)(&
Binges9+'@;5+'#"&+8##,+%5)$+)+$#"')*+(&"1#$+<#@*,+&)%+-$+)+15#"%+)'#@$%+#8+
%-'&
3*1#+1#'&+(&#(*&+;)$+e@1%+&)%+)+*#%+)%+#$&+%-'&A+D@%+$#%+D&+D@*-'-;
○
0-1;"-'-$)%-#$+D&%<&&$+,-1#",&"&,+D-$:&+)$,+)+:"#<%51+1(@"%+;)$+D&+
%"-;BI+D)1&,+#$+%5-1+;"-%&"-)
○
C%5&"+%5-$:1+%&$,+%#+:#+)*#$:+<-%5+,-1#",&"&,+D-$:&1+%5)%+')B&+%5&'+
'#"&+#D=-#@1
F&*8O;#$1;-#@1$&11L15)'&
§
M&"1#$+B$#<1+%5&I6"&+&)%-$:+'#"&+%5)$+%5&I+15#@*,+#"+$&&,+%#
§
HI(-;)**I+1%)"%+-$+1&;"&%+8#"+1&*8O;#'8#"%
§
○
78+%5&I6"&+e@1%+:)-$-$:+<&-:5%+)$,+$#%+,#-$:+)$I%5-$:A+-%61+binge-eating5
disorder
○
>
Compensatory5behaviors5are5to5counteract5the5effects5of5the5binge
0#&1$6%+')%%&"+5#<+&88&;%-=&+-%+-1
○
2)$+1#'&%-'&1+,&(&$,+#$+,"@:1+*-B&+'&%5+)$,+3,,&")**+%5)%+,&;"&)1&+
)((&%-%&+
○
>
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+<&-:5%
U&11+#8+)+,-1%#"%-#$A+'#"&+)+;5"#$-;+()%%&"$+#8+,-11)%-18);%-#$
○
>
F&=&"-%I+D)1&,+#$+$@'D&"+#8+;#'(&$1)%#"I+D&5)=-#"1 (&"+<&&B9
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
0FZON+;"-%&"-)+8#"+.YU7Z73+?KTgCF3
.-$:&1
T&;@""&$%+D-$:&13/
R+(&"+<&&B+8#"+W+'#$%51./
1.
2#'(&$1)%#"I+D&5)=-#"
g#'-%-$:3/
U)J)%-=&1./
KJ%"&'&+&J&";-1&2/
2.
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+-'):&
U#<+1&*8+&1%&&'+,@&+%#+D#,I+-'):&3/
3.
Binge)Eating)Disorder
Binge5eating5disorder9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*h+$#+;#'(&$1)%-$:
CD&1-%I+)$,+#=&"&)%-$:+)"&+'@;5+'#"&+("&=)*&$%+%5)$+D-$:&+&)%-$:+,-1#",&"+>
.-$:&+&)%-$:+1&=&"-%I+D)1&,+#$+$@'D&"+#8+D-$:&1
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
`)1+;#$%#@"1+#8+1@D1%)$;&+)D@1&A+'#"&+1#+%5)$+#%5&"+,-1#",&"1
.-$:&1+)"&+)**+;#$1@'-$:
○
U##B1+)+*#%+'#"&+$&@"#O;5&'-;)**I+*-B&+1@D1%)$;&+)D@1&
0#()'-$&+"&1(#$1&1+%#+8##,+"&*)%&,+;@&1
§
○
Z)B&1+-%+,-88&"&$%+8"#'+#%5&"+K01+D&;)@1&+#8+),,-;%-=&+"&1(#$1&+%#+8##,1
○
0-88-;@*%+D&;)@1&+I#@+5)=&+%#+&)%+Ealways5easier5to5abstain5that5use5in5
moderation <5&$+I#@6"&+),,-;%&,+%#+1#'&%5-$:
78+I#@+8-$,+-%+&)1-&"+%#+)D1%)-$+%5)$+@1&+1#'&%5-$:+-$+'#,&")%-#$A+-1+
)+1-:$+%5)%+I#@+')I+5)=&+)$+),,-;%-#$
§
]&6"&+1)%@")%&,+DI+),=&"%-1&'&$%1+%"I-$:+%#+:")D+#@"+)%%&$%-#$+%#+
@$5&)*%5I+8##,
."-:5%+;#*#"&,+();B):-$:A+8)1%+8##,i
§
○
>
F%@,I+<-%5+,-&%
H<#+:"#@(19
C":)$-;+5-:5+8)%+*#<+;)"D
§
C":)$-;+5-:5+;)"D+)$,+*#<+8)%+,-&%
§
○
.#%5+*#1%+)+*#%+#8+<&-:5%+)$,+1)'&+)'#@$%
0-,$6%+')%%&"
§
○
7'(#"%)$;&9+,-,+$#%+&)%+)$I%5-$:+("#;&11&,
○
>
0FZON+;"-%&"-)+8#"+.7?GK+K3H7?G+07FCT0KT
.-$:&1
T&;@""&$%+D-$:&13/
R++(&"+<&&B+8#"+W+'#$%51./
R/
.-$:&1+'@1%+-$;*@,&
K)%-$:+j@-;B*I3/
K)%-$:+)*#$&./
K)%-$:+@$%-*+#=&"+8@**2/
F&*8O*#)%5-$:+)8%&"<)",10/
a/
3D1&$;&+#8+;#'(&$1)%#"I+D&5)=-#"W/
K0+,-):$#1%-;+,-88&"&$%-)*1+k1&&+1*-,&l
F-:$-8-;)$%*I+*#<+.Z7
m&1+E3$#"&J-)
2#'(&$1)%-#$1_+.-$:&1_
?#E"&1%"-;%-=&+1@D%I(&
§
m&1+ED-$:&L(@":&+1@D%I(&
§
○
>
?#+ED-$:&1_>
Prevalence
3:&+#8+#$1&%
3$#"&J-)9+H&&$1L&)"*I+aS1>
?#+):&+;@%+#88+8#"+D-$:&O&)%-$:>
2#'#"D-,-%I
`-:5+;#'#"D-,-%I+<-%5+)$J-&%IA+,&("&11-#$A+1@D1%)$;&+)D@1&
U#<+D#,I+<&-:5%+*&),1+%#+')*$#@"-15'&$%+)$,+'##,+1I'(%#'1
0&("&11-#$+-1+%I(-;)**I+1&;#$,)"I+%#+)$#"&J-)
§
○
>
0&(&$,1+#$+-$,-=-,@)*+;)1&+5#<+,-1%-$;%+#"+-$%&";#$$&;%&,+%5&+;#'#"D-,-%I+-1
71+%5&+,&("&11-#$+,"-=-$:+%5&+;#'(&$1)%#"I+D&5)=-#"_
○
0&("&11&,+D&8#"&+K0_+C"+-1+,&("&11-#$+)+;#$1&j@&$;&+#8+K0+D&5)=-#"+)$,+
&88&;%1_
○
>
2#''#$+5)*8O%"@%51
K)%-$:+,-1#",&"1+)"&+")"&
2*-$-;)*+&)%-$:+,-1#",&"1+)"&+@$;#''#$A+D@%+,-1#",&"&,+&)%-$:+-1+
("&=)*&$%
○
`I(&"+8#;@1+#$+&)%-$:9+NNQ+#8+8&')*&1+)$,+aNQ+#8+')*&1+"&(#"%+,-&%-$:/+
RaQ+8&')*&1+)$,+WQ+')*&1+"&(#"%+D-$:&+&)%-$:
○
>
K)%-$:+,-1#",&"1+("-')"-*I+)88&;%+)88*@&$%+<5-%&+<#'&$
0-88&"&$%-)*+("&1&$%)%-#$1+DI+:&$,&"+)$,+");-)*L&%5$-;+D);B:"#@$,
○
0-88&"&$;&1+-$+<5#+1&&B1+%"&)%'&$%
○
?CH+,-1()"-%I+-$+("&=)*&$;&
○
>
H5&I+)"&+;)@1&,+DI+]&1%&"$+;@*%@"&
Z#1%+("&=)*&$%+-$+]&1%&"$+;@*%@"&
○
F%"#$:+:&$&%-;+;#'(#$&$%+VWNONNQ++;#$;#",)$;&+-$+'#$#4I:#%-;+%<-$1X
○
.&&$+)"#@$,+8#"+%5#@1)$,1+#8+I&)"1A+D&8#"&+]&1%&"$+;@*%@"&
?#%+)+DI("#,@;%+#8+]&1%&"$+;@*%@"&
§
○
>
H5&+.Z7+-1+)+:##,+'&)1@"&'&$%+#8+D#,I+5&)*%5
M&"1#$+R9+d6N+a\n+*D1A+.Z7+Wa/P+V#D&1&X+D@%+-1+)$+?!U+%-:5%O&$,
!@$;%-#$-$:+("#8&11-#$)*+)%5*&%&
§
○
>
Treatment
Z&,-;)%-#$
3$%-,&("&11)$%1+8#"+;#O'#"D-,+,&("&11-#$A+D@%+$#%+%5&+@$,&"*I-$:+;#"&+-11@&1+#8+
&)%-$:+,-1#",&"1
>
0#$6%+),,"&11+;#"&+8&)"1+#8+<&-:5%+:)-$>
2)$6%+"&'#=&+"&1%"-;%-=&+D&5)=-#"1>
2.H
Z#1%+<&**+1%@,-&,>
NSQ+&88&;%-=&>
!)'-*IO.)1&,+H5&")(I9+[NSQ+)%+D&1%
F#'&+@$<)$%&,+1-,&+&88&;%1
U-B&+#$*I+&)%-$:+<-%5+()"&$%)*+&$;#@"):&'&$%
§
U&)"$1+%#+&)%+)(("#("-)%&*I+#$*I+<5&$+D&-$:+;*#1&*I+'#$-%#"&,
U#1&+1B-**1+<5&$+*&)=-$:+5#'&+i
§
○
>
M"#;&11+8#"+)$#"&J-)+)$,+D@*-'-)9
7,&$%-8I+;)@1)*+,-1%#"%-#$1
○
H&1%+#@%+D&*-&81+)D#@%+1&*8+)$,+<&-:5%+V1&*8+'#$-%#"-$:X
○
0&(&$,-$:+#$+1&=&"-%IA+-$-%-)*+1%):&1+')I+"&j@-"&+5#1(-%)*-4)%-#$A+8#";&,+
&)%-$:
○
>
!)'-*I+%5&")(I
K0+;)$+#8%&$+)"-1&+-$+),#*&1;&$;&+)1+1I'(%#'+#8+8)'-*I+,I18@$;%-#$
○
H"&)%-$:+8)'-*I+-11@&1+;)$+"&,@;&+,"-=&+8#"+K0+D&5)=-#"
○
K)"*I+<&-:5%O:)-$+("&,-;%1+"&1(#$1&+
○
>
7,&$%-8I-$:+'##,L&=&$%+"&*)%&,+&)%-$:+D&5)=-#"
2)$+5&*(+)=#-,+%5-1+-89
?&&,+%#+:#+-$+<-%5+)+(*)$+D&;)@1&+1&&-$:+%5&+;@&+<-**+;5)$:&+
"&1#*=&
○
○
M"#D*&'1+8#"+$&&,-$:+%5-1+;)$+-$;*@,&9
.-$:-$:+)1+)+,-1%");%-#$
○
.-$:-$:+)$,+;#'(&$1)%-$:+D#%5+,)'(&$+'##,1
○
T&1%"-;%-$:+-$%)B&+%#+8&&*+-$+;#$%"#*L);;#'(*-15&,
○
T&1%"-;%&,+)1+%#+,&'#$1%")%&+)$:&"A+#"+)1+)$+);%+#8+,&8-)$;&
○
○
>
Eating)Disorders
H@&1,)IA+ 3("-*+RPA+aSR\ RR9ad+3Z
Learning Catalytics
Mary, a 70-year-old woman, was hospitalized for hip surgery. Although there
were no immediate complications from the surgery, her son became concerned
when he visited her that night because she was not making any sense. She
thanked him for checking her into the Ritz Carlton and laughed giddily when he
told her that she was in the hospital. Half an hour later, she began sobbing.
Although she seemed fine the next morning, symptoms of acute confusion
reemerged by lunchtime. Which diagnosis is most likely for Mary?
DeliriumA.
!"#$%#%&'(#")*+,&'&$%-)./
.-(#*)"+0-1#",&"2/
3*45&-'&"61+,-1&)1&0/
7'(#"%)$%+-$8#9+%5&+%-'-$:+)$,+,&:"&&+#8+;5)$:&
!"#$%#%&'(#")*+,#&1$6%+15#<+')11-=&+,")')%-;+;5)$:&1+#=&"+$-:5%>
?#+#%5&"+;)@1&A+;#@*,+1&&'+*-B&+")(-,+#$1&%>
CD=-#@1+;)$,-,)%&+E%5&+)$&1%5&1-)+;)$+5)=&+"&1-,@)*+)8%&"+&88&;%1>
Which neurotransmitter is most involved in the treatment of Alzheimer’s disease?
0#()'-$&3/
F&"#%#$-$./
G*@%)')%&2/
Acetylcholine
H"&)%'&$%+-1+)$+-$5-D-%#"+#$+%5-1+1I1%&'
○
D.
The most successful treatments for eating disorders are (select all that apply):
CBTA.
Family5TherapyB.
3$%-,&("&11)$%1
2)$+D&+@1&,+%#+%"&)%+;#'#"D-,+)$J-&%I+#"+,&("&11-#$)/
0#&1+$#%+-'("#=&+%5&+K0+-%1&*8D/
2/
.&$4#,-)4-(-$&10/
3$%-(1I;5#%-;1K/
The main distinguishing factor between anorexia and bulimia is:
.-$:-$:LM@":-$:
H5&"&+-1+)+1@D%I(&+-$+)$#"&J-)
○
3/
Body5weight
3$#"&J-)+E5)=&+)$+)D$#"')*+D#,I+<&-:5%
○
.@*-'-)+E')-$%)-$+)+$#"')*+D#,I+<&-:5%
○
B.
2#:$-%-=&+,-1%#"%-#$1+)"#@$,+D#,I+-'):&2/
(##"+-'(@*1&+;#$%"#*0/
Lifetime prevalence for eating disorders is:
1-3%A.
NOPQ./
RSQ2/
RNQ0/
T&*)%-=&*I+")"&+-$+%&"'1+#8+'&&%-$:+8@**+;"-%&"-)
0-1#",&"&,+&)%-$:+-1+$#%+=&"I+")"&
K1(&;-)**I+<-%5+#%5&"+;#'#"D-,+,-1#",&"1
○
>
U-8&%-'&+("&=)*&$;&+#8+&)%-$:+,-1#",&"1+-1+"&*)%-=&*I+*#<+VROWQX>
Anorexia)Nervosa
25)");%&"-4&,+DI9
Y$5&)*%5I+D#,I+<&-:5%>
M"&#;;@()%-#$+<-%5+D#,I+-'):&>
F@D%I(&1+#8+"&1%"-;%-=&+#"+D-$:&L(@":&>
0FZON+;"-%&"-)+8#"+ANOREXIA5NERVOSA
T&1%"-;%-#$
T&1%"-;%-#$+D&5)=-#"1+V.Z7+[+R\/NX3/
1.
]&-:5%O"&*)%&,+)$J-&%I
7$%&$1&+8&)"+#8+<&-:5%+:)-$3/
?#+1@;5+%5-$:+)1+^%##+%5-$^./
2.
0-1%#"%&,+D#,I+-'):&
M"&#;;@()%-#$+<-%5+)((&)")$;&+)$,+D#,I+()"%13/
3.
]5)%+-1+)+5&)*%5I+<&-:5%_
`&)*%5I9+R\Oab>
.Z7+1&=&"-%I9
Z-*,9+cRP
○
Z#,&")%&9+RdORP
○
F&=&"&9+RNORP
○
KJ%"&'&9+[RN
○
>
M5I1-;)*+')"B&"1+#8+*#<+<&-:5%
K');-)%&,+)((&)")$;&
○
!)%-:@&
○
0-44-$&11+#"+8)-$%$&11
○
."-%%*&L;");B&,+$)-*1+V$#%+&$#@:5+;)*;-@'X
○
H5-$$-$:+5)-"
○
Z&$1%"@)*+;I;*&+-""&:@*)"-%-&1+
○
>
U)D#")%#"I+')"B&"1+#8+*#<+<&-:5%9
U&@B#(&$-)+V*#<+;&**+ ;#@$%X
○
K*&=)%-#$1+-$+5&()%-;+V*-=&"X+&$4I'&1
○
F-$@1+D"),I;)",-)
`&)"%+-""&:@*)"-%I+V*#<&"+%5)$+dS+D('X
§
○
U#<+D#$&+')11
○
U#<+"&1%-$:+'&%)D#*-;+);%-=-%I
.#,I+%"I-$:+%#+1)=&+&$&":I
§
○
U#<+1&J+5#"'#$&1
K1%"#:&$+8#"+<#'&$
§
H&1%#1%&"#$&+8#"+'&$
§
○
>
M5I1-;)*+)$,+*)D+')"B&"1+`KUM+;#$8-"'+)+,-):$#1-1A+D@%+,#$6%+,&8-$&+-%
F#'&#$&+-$+),#*&1;&$;&+<)1+=&"I+%5-$+D@%+,#$6%+<#""I+)D#@%+8##,A+)$,+
8"#'+D#,I61+(&"1(&;%-=&+-1+#B)I
○
?CH+)+,&8-$-%-=&+,-):$#1%-;+%&1%
○
>
7$O;*)11+=-,
3+*#%+#8+,&$-)*+)$,+,-1%#"%-#$
2)$+;#'&+;*#1&+%#+,I-$:+8"#'+')*$@%"-%-#$+D&8#"&+)$I+);%-#$+-1+%)B&$
○
>
7$%&$1&+"&1%"-;%-=&+D&5)=-#"1+
F%)"%&,+*#1-$:+<&-:5%A+%5&$+1%)"%&,+5)$:-$:+#@%+<-%5+8"-&$,1+<&**
○
!-:@"&+#@%+)+<)I+%#+"&1%"-;%+)$,+in#the#initial#stages,#get#a#lot#of#positive#
reinforcement
T&)88-"'1+-,&)+%5)%+I#@+5),+D&&$+#=&"<&-:5%+)$,+;#$%"#**-$:+<&-:5%+
-1+)+(#<&"8@*+)$,+@1&8@*+%5-$:+%#+,#
§
○
>
Being5underweight5has5a5lot5more5severe5consequences5and5may5require5emergency5
treatmentA+1#+)$#"&J-)+)$,+D@*-'-)+)"&+1&()")%&+,-):$#1&1
Bulimia
Bulimia9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*A+;#'(&$1)%-$:A+#=&"O&=)*@)%-#$+#8+<&-:5%+
)$,+15)(&
Binges9+'@;5+'#"&+8##,+%5)$+)+$#"')*+(&"1#$+<#@*,+&)%+-$+)+15#"%+)'#@$%+#8+
%-'&
3*1#+1#'&+(&#(*&+;)$+e@1%+&)%+)+*#%+)%+#$&+%-'&A+D@%+$#%+D&+D@*-'-;
○
0-1;"-'-$)%-#$+D&%<&&$+,-1#",&"&,+D-$:&+)$,+)+:"#<%51+1(@"%+;)$+D&+
%"-;BI+D)1&,+#$+%5-1+;"-%&"-)
○
C%5&"+%5-$:1+%&$,+%#+:#+)*#$:+<-%5+,-1#",&"&,+D-$:&1+%5)%+')B&+%5&'+
'#"&+#D=-#@1
F&*8O;#$1;-#@1$&11L15)'&
§
M&"1#$+B$#<1+%5&I6"&+&)%-$:+'#"&+%5)$+%5&I+15#@*,+#"+$&&,+%#
§
HI(-;)**I+1%)"%+-$+1&;"&%+8#"+1&*8O;#'8#"%
§
○
78+%5&I6"&+e@1%+:)-$-$:+<&-:5%+)$,+$#%+,#-$:+)$I%5-$:A+-%61+binge-eating5
disorder
○
>
Compensatory5behaviors5are5to5counteract5the5effects5of5the5binge
0#&1$6%+')%%&"+5#<+&88&;%-=&+-%+-1
○
2)$+1#'&%-'&1+,&(&$,+#$+,"@:1+*-B&+'&%5+)$,+3,,&")**+%5)%+,&;"&)1&+
)((&%-%&+
○
>
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+<&-:5%
U&11+#8+)+,-1%#"%-#$A+'#"&+)+;5"#$-;+()%%&"$+#8+,-11)%-18);%-#$
○
>
F&=&"-%I+D)1&,+#$+$@'D&"+#8+;#'(&$1)%#"I+D&5)=-#"1 (&"+<&&B9
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
0FZON+;"-%&"-)+8#"+.YU7Z73+?KTgCF3
.-$:&1
T&;@""&$%+D-$:&13/
R+(&"+<&&B+8#"+W+'#$%51./
1.
2#'(&$1)%#"I+D&5)=-#"
g#'-%-$:3/
U)J)%-=&1./
KJ%"&'&+&J&";-1&2/
2.
KJ%"&'&+("&#;;@()%-#$+<-%5+D#,I+-'):&
U#<+1&*8+&1%&&'+,@&+%#+D#,I+-'):&3/
3.
Binge)Eating)Disorder
Binge5eating5disorder9+D-$:&+&)%-$:+<-%5+*#11+#8+;#$%"#*h+$#+;#'(&$1)%-$:
CD&1-%I+)$,+#=&"&)%-$:+)"&+'@;5+'#"&+("&=)*&$%+%5)$+D-$:&+&)%-$:+,-1#",&"+>
.-$:&+&)%-$:+1&=&"-%I+D)1&,+#$+$@'D&"+#8+D-$:&1
Z-*,9+ROW+
○
Z#,&")%&9+bOP
○
F&=&"&9+\ORW
○
KJ%"&'&9+fRb
○
>
`)1+;#$%#@"1+#8+1@D1%)$;&+)D@1&A+'#"&+1#+%5)$+#%5&"+,-1#",&"1
.-$:&1+)"&+)**+;#$1@'-$:
○
U##B1+)+*#%+'#"&+$&@"#O;5&'-;)**I+*-B&+1@D1%)$;&+)D@1&
0#()'-$&+"&1(#$1&1+%#+8##,+"&*)%&,+;@&1
§
○
Z)B&1+-%+,-88&"&$%+8"#'+#%5&"+K01+D&;)@1&+#8+),,-;%-=&+"&1(#$1&+%#+8##,1
○
0-88-;@*%+D&;)@1&+I#@+5)=&+%#+&)%+Ealways5easier5to5abstain5that5use5in5
moderation <5&$+I#@6"&+),,-;%&,+%#+1#'&%5-$:
78+I#@+8-$,+-%+&)1-&"+%#+)D1%)-$+%5)$+@1&+1#'&%5-$:+-$+'#,&")%-#$A+-1+
)+1-:$+%5)%+I#@+')I+5)=&+)$+),,-;%-#$
§
]&6"&+1)%@")%&,+DI+),=&"%-1&'&$%1+%"I-$:+%#+:")D+#@"+)%%&$%-#$+%#+
@$5&)*%5I+8##,
."-:5%+;#*#"&,+();B):-$:A+8)1%+8##,i
§
○
>
F%@,I+<-%5+,-&%
H<#+:"#@(19
C":)$-;+5-:5+8)%+*#<+;)"D
§
C":)$-;+5-:5+;)"D+)$,+*#<+8)%+,-&%
§
○
.#%5+*#1%+)+*#%+#8+<&-:5%+)$,+1)'&+)'#@$%
0-,$6%+')%%&"
§
○
7'(#"%)$;&9+,-,+$#%+&)%+)$I%5-$:+("#;&11&,
○
>
0FZON+;"-%&"-)+8#"+.7?GK+K3H7?G+07FCT0KT
.-$:&1
T&;@""&$%+D-$:&13/
R++(&"+<&&B+8#"+W+'#$%51./
R/
.-$:&1+'@1%+-$;*@,&
K)%-$:+j@-;B*I3/
K)%-$:+)*#$&./
K)%-$:+@$%-*+#=&"+8@**2/
F&*8O*#)%5-$:+)8%&"<)",10/
a/
3D1&$;&+#8+;#'(&$1)%#"I+D&5)=-#"W/
K0+,-):$#1%-;+,-88&"&$%-)*1+k1&&+1*-,&l
F-:$-8-;)$%*I+*#<+.Z7
m&1+E3$#"&J-)
2#'(&$1)%-#$1_+.-$:&1_
?#E"&1%"-;%-=&+1@D%I(&
§
m&1+ED-$:&L(@":&+1@D%I(&
§
○
>
?#+ED-$:&1_>
Prevalence
3:&+#8+#$1&%
3$#"&J-)9+H&&$1L&)"*I+aS1>
?#+):&+;@%+#88+8#"+D-$:&O&)%-$:>
2#'#"D-,-%I
`-:5+;#'#"D-,-%I+<-%5+)$J-&%IA+,&("&11-#$A+1@D1%)$;&+)D@1&
U#<+D#,I+<&-:5%+*&),1+%#+')*$#@"-15'&$%+)$,+'##,+1I'(%#'1
0&("&11-#$+-1+%I(-;)**I+1&;#$,)"I+%#+)$#"&J-)
§
○
>
0&(&$,1+#$+-$,-=-,@)*+;)1&+5#<+,-1%-$;%+#"+-$%&";#$$&;%&,+%5&+;#'#"D-,-%I+-1
71+%5&+,&("&11-#$+,"-=-$:+%5&+;#'(&$1)%#"I+D&5)=-#"_
○
0&("&11&,+D&8#"&+K0_+C"+-1+,&("&11-#$+)+;#$1&j@&$;&+#8+K0+D&5)=-#"+)$,+
&88&;%1_
○
>
2#''#$+5)*8O%"@%51
K)%-$:+,-1#",&"1+)"&+")"&
2*-$-;)*+&)%-$:+,-1#",&"1+)"&+@$;#''#$A+D@%+,-1#",&"&,+&)%-$:+-1+
("&=)*&$%
○
`I(&"+8#;@1+#$+&)%-$:9+NNQ+#8+8&')*&1+)$,+aNQ+#8+')*&1+"&(#"%+,-&%-$:/+
RaQ+8&')*&1+)$,+WQ+')*&1+"&(#"%+D-$:&+&)%-$:
○
>
K)%-$:+,-1#",&"1+("-')"-*I+)88&;%+)88*@&$%+<5-%&+<#'&$
0-88&"&$%-)*+("&1&$%)%-#$1+DI+:&$,&"+)$,+");-)*L&%5$-;+D);B:"#@$,
○
0-88&"&$;&1+-$+<5#+1&&B1+%"&)%'&$%
○
?CH+,-1()"-%I+-$+("&=)*&$;&
○
>
H5&I+)"&+;)@1&,+DI+]&1%&"$+;@*%@"&
Z#1%+("&=)*&$%+-$+]&1%&"$+;@*%@"&
○
F%"#$:+:&$&%-;+;#'(#$&$%+VWNONNQ++;#$;#",)$;&+-$+'#$#4I:#%-;+%<-$1X
○
.&&$+)"#@$,+8#"+%5#@1)$,1+#8+I&)"1A+D&8#"&+]&1%&"$+;@*%@"&
?#%+)+DI("#,@;%+#8+]&1%&"$+;@*%@"&
§
○
>
H5&+.Z7+-1+)+:##,+'&)1@"&'&$%+#8+D#,I+5&)*%5
M&"1#$+R9+d6N+a\n+*D1A+.Z7+Wa/P+V#D&1&X+D@%+-1+)$+?!U+%-:5%O&$,
!@$;%-#$-$:+("#8&11-#$)*+)%5*&%&
§
○
>
Treatment
Z&,-;)%-#$
3$%-,&("&11)$%1+8#"+;#O'#"D-,+,&("&11-#$A+D@%+$#%+%5&+@$,&"*I-$:+;#"&+-11@&1+#8+
&)%-$:+,-1#",&"1
>
0#$6%+),,"&11+;#"&+8&)"1+#8+<&-:5%+:)-$>
2)$6%+"&'#=&+"&1%"-;%-=&+D&5)=-#"1>
2.H
Z#1%+<&**+1%@,-&,>
NSQ+&88&;%-=&>
!)'-*IO.)1&,+H5&")(I9+[NSQ+)%+D&1%
F#'&+@$<)$%&,+1-,&+&88&;%1
U-B&+#$*I+&)%-$:+<-%5+()"&$%)*+&$;#@"):&'&$%
§
U&)"$1+%#+&)%+)(("#("-)%&*I+#$*I+<5&$+D&-$:+;*#1&*I+'#$-%#"&,
U#1&+1B-**1+<5&$+*&)=-$:+5#'&+i
§
○
>
M"#;&11+8#"+)$#"&J-)+)$,+D@*-'-)9
7,&$%-8I+;)@1)*+,-1%#"%-#$1
○
H&1%+#@%+D&*-&81+)D#@%+1&*8+)$,+<&-:5%+V1&*8+'#$-%#"-$:X
○
0&(&$,-$:+#$+1&=&"-%IA+-$-%-)*+1%):&1+')I+"&j@-"&+5#1(-%)*-4)%-#$A+8#";&,+
&)%-$:
○
>
!)'-*I+%5&")(I
K0+;)$+#8%&$+)"-1&+-$+),#*&1;&$;&+)1+1I'(%#'+#8+8)'-*I+,I18@$;%-#$
○
H"&)%-$:+8)'-*I+-11@&1+;)$+"&,@;&+,"-=&+8#"+K0+D&5)=-#"
○
K)"*I+<&-:5%O:)-$+("&,-;%1+"&1(#$1&+
○
>
7,&$%-8I-$:+'##,L&=&$%+"&*)%&,+&)%-$:+D&5)=-#"
2)$+5&*(+)=#-,+%5-1+-89
?&&,+%#+:#+-$+<-%5+)+(*)$+D&;)@1&+1&&-$:+%5&+;@&+<-**+;5)$:&+
"&1#*=&
○
○
M"#D*&'1+8#"+$&&,-$:+%5-1+;)$+-$;*@,&9
.-$:-$:+)1+)+,-1%");%-#$
○
.-$:-$:+)$,+;#'(&$1)%-$:+D#%5+,)'(&$+'##,1
○
T&1%"-;%-$:+-$%)B&+%#+8&&*+-$+;#$%"#*L);;#'(*-15&,
○
T&1%"-;%&,+)1+%#+,&'#$1%")%&+)$:&"A+#"+)1+)$+);%+#8+,&8-)$;&
○
○
>
Eating)Disorders
H@&1,)IA+ 3("-*+RPA+aSR\ RR9ad+3Z
Document Summary
Mary, a 70-year-old woman, was hospitalized for hip surgery. Although there were no immediate complications from the surgery, her son became concerned when he visited her that night because she was not making any sense. She thanked him for checking her into the ritz carlton and laughed giddily when he told her that she was in the hospital. Although she seemed fine the next morning, symptoms of acute confusion reemerged by lunchtime. Important info: the timing and degree of change. Frontotemporal doesn"t show massive dramatic changes over night. No other cause, could seem like rapid onset. Obvious candidate the anesthesia can have residual after effects. The most successful treatments for eating disorders are (select all that apply): Can be used to treat comorbid anxiety or depression. The main distinguishing factor between anorexia and bulimia is: Cognitive distortions around body image poor impulse control. Relatively rare in terms of meeting full criteria. Lifetime prevalence of eating disorders is relatively low (1-3%)
